NewsAsia Bringing you the latest Business News from the Science Industry By Gwyneth Astles
Hellma Celebrates 10 Year Anniversary of Asia Pacific Headquarters in Singapore
Hellma GmbH, a pioneer in the manufacturing of quartz and glass optical components for scientific analysis has been supplying high precision optics to renowned analytical instrument manufacturers as well as scientists in the area of spectrophotometry since 1922.
This year commemorates the 10th anniversary of its Asia Pacific headquarter office in Singapore, which was set up in 2001 to strengthen Hellma’s presence in Asia Pacific. This operation supports Hellma’s clients and OEM partners in the area of sales and marketing, technical as well as logistics. Hellma Asia Pacific reaches out to the clients via a network of more than 15 distributors. Mr Lutz Mayer, Chief Executive Officer of Hellma Group, shared that: “Asia Pacific is one of the fastest growing market for Hellma. South Asia was recently added into Singapore headquarter’s portfolio and the performance was impressive within the first quarter of the first year. I’m very pleased with this achievement and would like to express my gratitude to all colleagues at Asia Pacific office who contributed to this.”
Hellma Asia Pacific has chosen AnaLab Asia 2011 as the highlight of the celebration. Distributors from the region as well as Hellma directors from Germany will be gathering at Hellma’s booth to toast to this special occasion. There will be a meeting to summarise the week’s celebration and to update the distributors of upcoming new projects. On the current market’s opportunities and threats, Mr Lutz Mayer added: “The clients’ purchasing pattern is influenced by tighter funding and availability of alternative brands. Hellma is a very established player in the market and we offer a wider range of products compared to our competitors. We are also tapping on collaborations with well-known instrument manufacturers to promote our products. In addition, instead of just producing a product for our client, Hellma positions the company as a
solutions provider for every requirement.”
The company now divides its product portfolio into Cells, Micro Volume Analysis, Calibration Standards, Fibre-Optical Systems and Flow Channels. There are 13 subsidiaries worldwide to cater to the growing market.
TO FIND OUT MORE CIRCLE NO. 304
The Place to be in 2012
For any company who is looking to grow their business in the Far East especially in Indonesia then InaPharm or InaChem is the place to be in July 2012. The premier B2B trade fair dedicated to the pharmaceutical industry in Indonesia, InaPharm is a three day industry event running alongside the 2nd edition of InaChem - the Indonesia International Chemical Exhibition and Chemical Engineering Conference. InaChem is the largest chemical
industry event in Indonesia and focuses on a diverse range of chemical, analytical and process engineering technologies. InaChem featured 130 exhibitors at the 2010 event and attracted more than 4,500 high-calibre visitors from 13 countries. InaPharm will offer European organisations unlimited deal making and networking opportunities as well as a chance to meet with producers, processors, technology suppliers and consumers across the entire value chain of the Indonesian pharmaceutical industry. In 2010 Indonesia’s pharmaceutical market value was estimated to be worth Rp 37,52 trillion (US$4.1billion). The industry is projected to grow by 12 to 14% in the coming years and forecast to be the sixth largest pharmaceutical market in the Asia Pacific region by 2016.
InaPharm, the Indonesia International Pharmaceutical Ingredients Manufacturing &
Technology Expo, has appointed marketing communications specialist, Phoenix MarCom of Cambridge, UK, as its exclusive European agency to promote InaPharm’s event in 2012 to European companies. Phoenix MarCom, which is also exclusive European agent for InaPharm’s sister Indonesian event InaChem, is capable of delivering a wide variety of support services and marketing expertise to any European based exhibitors that sign up for either event.
“Almost 90% of Indonesia’s pharmaceutical raw materials are imported from overseas – mainly from China, India, US and Europe,” explained Malcolm Lee, Phoenix MarCom’s Business Development Manager. “For 2011-12, investment in the Indonesian pharmaceutical sector is targeted to grow by 50% to 60% from US$500 million to US$750 - 800 million as a
result of the Indonesian Government’s policy to give more opportunity for foreign ownership. The policy aims to help Indonesia become a globally significant production base for international pharmaceutical manufacturing companies. At this moment, Indonesia is one of the few growth areas worldwide which makes both InaPharm and InaChem ideal events for European companies who are looking to expand into the South East Asian region. An added attraction for European businesses is the highly cost effective booth space being offered by both events so it is wise to book a booth as soon as possible to ensure participation in these key events. Both shows are supported by excellent regional media coverage that is going to attract large numbers of potential customers in what is promising to be a very large, vibrant market.”
TO FIND OUT MORE CIRCLE NO. 305
Leica Microsystems Acquires Labindia’s Microscopy and Histopathology Divisions
Leica Microsystems, a leading provider of microscopy systems and total histology solutions, recently announced that it has acquired the microscopy and histopathology business of Labindia Instruments Pvt Ltd, a leading solutions and service provider in India. This transition comes after more than 20 years during which Labindia has successfully distributed Leica’s products in India. Over 130 associates from Labindia have transferred to Leica Microsystems to sustain continuity for existing customers who will continue to benefit from Labindia’s wide experience of their needs and applications. In effect the acquisition is a
natural culmination of a long and fruitful partnership and supports Leica Microsystems’ strategy to expand its operations in India. “Leica Microsystems’ expansion of its commercial operations in India creates extended opportunities for interaction, collaboration and innovation to benefit all of our customers in the life sciences, industrial laboratories and hospitals for both diagnostics and surgery,” explained Arnd Kaldowski, President Leica Microsystems. “This acquisition will enable closer contact with our customers so that we can better support them in their day-to-day work.”
Labindia’s and Leica Microsystems’ shared history dates back to the end of the 1980s when the Indian company started serving Indian customers of Reichert Jung, which shortly afterwards became part of Leica. Vijay Bibikar, Director Labindia, commented: “We are convinced that at this point in time this agreement is a logical further step in the long history of close cooperation between Labindia and Leica Microsystems and that it will be beneficial to all our customers.” Kaldowski said: “We highly appreciate the work that our partner Labindia has done driving our business in India to its present high level. We are excited
about the future potential of the Indian market and the potential to help our customers to meet with their professional challenges.”
TO FIND OUT MORE CIRCLE NO. 306
To be included in our next issue, send all your Business and Financial News stories to
gwyneth@intlabmate.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44
